134 related articles for article (PubMed ID: 35841433)
1. MRI-guided DBS of STN under general anesthesia for Parkinson's disease: results and microlesion effect analysis.
Soler-Rico M; Peeters JB; Joris V; Delavallée M; Duprez T; Raftopoulos C
Acta Neurochir (Wien); 2022 Sep; 164(9):2279-2286. PubMed ID: 35841433
[TBL] [Abstract][Full Text] [Related]
2. STN DBS for Parkinson's disease: results from a series of ten consecutive patients implanted under general anaesthesia with intraoperative use of 3D fluoroscopy to control lead placement.
Delavallée M; Delaunois J; Ruwet J; Jeanjean A; Raftopoulos C
Acta Neurochir (Wien); 2016 Sep; 158(9):1783-8. PubMed ID: 27405941
[TBL] [Abstract][Full Text] [Related]
3. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI.
Matias CM; Frizon LA; Nagel SJ; Lobel DA; Machado AG
J Neurosurg; 2018 Dec; 129(6):1572-1578. PubMed ID: 29372880
[TBL] [Abstract][Full Text] [Related]
4. [A Clinical Study of Patients with Primary Parkinson's Disease Undergoing Bilateral Deep Brain Stimulation (STN-DBS) Surgery in the Subthalamic Nucleus under General Anesthesia].
Shi YF; Zhang Y; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):583-587. PubMed ID: 35871727
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
6. The Role of 3T Magnetic Resonance Imaging for Targeting the Human Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease.
Longhi M; Ricciardi G; Tommasi G; Nicolato A; Foroni R; Bertolasi L; Beltramello A; Moretto G; Tinazzi M; Gerosa M
J Neurol Surg A Cent Eur Neurosurg; 2015 May; 76(3):181-9. PubMed ID: 25764475
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
[TBL] [Abstract][Full Text] [Related]
9. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results.
Harries AM; Kausar J; Roberts SA; Mocroft AP; Hodson JA; Pall HS; Mitchell RD
J Neurosurg; 2012 Jan; 116(1):107-13. PubMed ID: 21999316
[TBL] [Abstract][Full Text] [Related]
10. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
[TBL] [Abstract][Full Text] [Related]
12. Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy.
Starr PA; Martin AJ; Ostrem JL; Talke P; Levesque N; Larson PS
J Neurosurg; 2010 Mar; 112(3):479-90. PubMed ID: 19681683
[TBL] [Abstract][Full Text] [Related]
13. Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease.
Tykocki T; Nauman P; Koziara H; Mandat T
Stereotact Funct Neurosurg; 2013; 91(1):12-7. PubMed ID: 23154788
[TBL] [Abstract][Full Text] [Related]
14. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
[TBL] [Abstract][Full Text] [Related]
16. The Intraoperative Microlesion Effect Positively Correlates With the Short-Term Clinical Effect of Deep Brain Stimulation in Parkinson's Disease.
Lange SF; Kremer NI; van Laar T; Lange F; Steendam-Oldekamp TE; Oterdoom DLM; Absalom AR; van Dijk JMC; Drost G
Neuromodulation; 2023 Feb; 26(2):459-465. PubMed ID: 34494335
[TBL] [Abstract][Full Text] [Related]
17. A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.
Lahtinen MJ; Haapaniemi TH; Kauppinen MT; Salokorpi N; Heikkinen ER; Katisko JP
Acta Neurochir (Wien); 2020 May; 162(5):1067-1076. PubMed ID: 32103343
[TBL] [Abstract][Full Text] [Related]
18. The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
Vinke RS; Selvaraj AK; Geerlings M; Georgiev D; Sadikov A; Kubben PL; Doorduin J; Praamstra P; Bloem BR; Bartels RHMA; Esselink RAJ
J Parkinsons Dis; 2022; 12(4):1269-1278. PubMed ID: 35367970
[TBL] [Abstract][Full Text] [Related]
19. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
